In case you missed it: Feb. 7 to Feb. 11
A look back on this week's news.
Optimal prenatal opioid use disorder care may reduce odds of preterm birth
An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.
Marijuana exposure during pregnancy may increase adverse birth outcomes
A review and meta-analysis in JAMA Network Open revealed women exposed to marijuana in pregnancy were at significantly increased risk for adverse neonatal outcomes, including low birth weight, small for gestational age, and preterm delivery.
A noninfectious "infection" after cesarean delivery
Experts evaluate 3 clinical scenarios and determine the appropriate course of action.
CooperSurgical to acquire the Cook Medical’s Reproductive Health division
CooperSurgical, Inc, a global provider of health products for women, babies, and families, announced Monday plans to acquire the Reproductive Health division of Cook Medical, a manufacturer for minimally invasive medical devices in the fertility, obstetrics, and gynecology markets.
The current state of uterine fibroid care
“Over 70% of women are estimated to develop uterine fibroids by age 50,” said senior author Irene Aninye, PhD, chief science officer for the Society for Women’s Health Research (SWHR) in Washington, D.C. “Fibroids are a complex condition that can range from being asymptomatic to having deleterious effects on a woman’s health and quality of life.”
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
